AU2002343417A1 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
AU2002343417A1
AU2002343417A1 AU2002343417A AU2002343417A AU2002343417A1 AU 2002343417 A1 AU2002343417 A1 AU 2002343417A1 AU 2002343417 A AU2002343417 A AU 2002343417A AU 2002343417 A AU2002343417 A AU 2002343417A AU 2002343417 A1 AU2002343417 A1 AU 2002343417A1
Authority
AU
Australia
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002343417A
Inventor
Vinod Asundi
Rodoje T. Drmanac
Malabika Ghosh
Dana Haley-Vicente
Yunqing Ma
Feiyan Ren
Tom Y. Tang
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Gezhi Weng
Aidong J. Xue
Jie Zhang
Qing A. Zhao
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of AU2002343417A1 publication Critical patent/AU2002343417A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002343417A 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides Abandoned AU2002343417A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US60/324,631 2001-09-24
PCT/US2002/030474 WO2003029271A2 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Publications (1)

Publication Number Publication Date
AU2002343417A1 true AU2002343417A1 (en) 2003-04-14

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002343417A Abandoned AU2002343417A1 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Country Status (4)

Country Link
EP (1) EP1430112A4 (en)
AU (1) AU2002343417A1 (en)
CA (1) CA2461280A1 (en)
WO (1) WO2003029271A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281437T3 (en) 2000-08-22 2007-10-01 Agensys, Inc. NUCLEIC ACID AND CORRESPONDING PROTEIN DENOMINATED 158P1D7 USEFUL FOR THE TREATMENT AND DETECTION OF BLADDER CANCER AND OTHER CANCERES.
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002032962A2 (en) 2000-10-20 2002-04-25 Millennium Pharmaceuticals, Inc. Compositions of human proteins and method of use thereof
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
AU2002254615A1 (en) * 2001-04-17 2002-10-28 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
FR2836687A1 (en) * 2002-03-04 2003-09-05 Gene Signal GENES INVOLVED IN THE REGULATION OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR APPLICATIONS
CA2527571A1 (en) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
WO2005111213A1 (en) * 2004-05-18 2005-11-24 Kurume University Target gene mimitin of myc
WO2006035741A1 (en) 2004-09-29 2006-04-06 Dainippon Sumitomo Pharma Co., Ltd. Gene expressed specifically in es cells and utilization of the same
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
WO2008054534A2 (en) 2006-05-11 2008-05-08 Quark Pharmaceuticals, Inc. Screening systems utilizing rtp801
EP2026843A4 (en) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Therapeutic uses of inhibitors of rtp801l
ES2421407T3 (en) * 2007-02-09 2013-09-02 Gene Signal Int Sa Wound healing agent and composition
EP1980254A1 (en) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Means and methods for counteracting protein aggregation
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (en) * 2010-03-11 2013-05-23 Intec Systems Institute Inc Diagnostic marker for lung cancer or cervical cancer
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
US20130210739A1 (en) * 2010-07-21 2013-08-15 Universite Pierre Et Marie Curie (Paris 6) Bhlh proteins and their use as drugs
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc Substituted phosphorothioate nucleotide analogs
CN104321333A (en) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
SG10201701424QA (en) 2012-08-23 2017-04-27 Agensys Inc Antibody drug conjugates (adc) that bind to 158p1d7 proteins
LT3388075T (en) 2015-03-27 2023-11-10 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
WO2022216856A1 (en) * 2021-04-06 2022-10-13 Board Of Regents, The University Of Texas System Methods and compositions comprising mhc class i peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US20020150898A1 (en) * 2000-04-18 2002-10-17 Tang Y. Tom Novel nucleic acids and polypeptides
US20030212257A1 (en) * 2001-04-03 2003-11-13 Spytek Kimberly A. Novel human proteins, polynucleotides encoding them and methods of using the same

Also Published As

Publication number Publication date
WO2003029271A2 (en) 2003-04-10
CA2461280A1 (en) 2003-04-10
WO2003029271A3 (en) 2003-11-20
EP1430112A2 (en) 2004-06-23
EP1430112A4 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (en) Novel nucleic acids and polypeptides
AU2002368010A1 (en) Novel nucleic acids and secreted polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
EP1368475A4 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2002367815A1 (en) Novel nucleic acids and secreted polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase